nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—OPRD1—coronary artery disease	0.213	0.714	CbGaD
Methadone—CYP2C19—coronary artery disease	0.0852	0.286	CbGaD
Methadone—CYP2C8—Fenofibrate—coronary artery disease	0.0133	0.0267	CbGbCtD
Methadone—CYP2B6—Clopidogrel—coronary artery disease	0.0122	0.0245	CbGbCtD
Methadone—CYP3A7—Eplerenone—coronary artery disease	0.0119	0.0239	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0119	0.0239	CbGbCtD
Methadone—CYP2C8—Gemfibrozil—coronary artery disease	0.0106	0.0214	CbGbCtD
Methadone—ABCB1—Ticagrelor—coronary artery disease	0.0101	0.0203	CbGbCtD
Methadone—CYP3A5—Clopidogrel—coronary artery disease	0.0096	0.0193	CbGbCtD
Methadone—CYP2C9—Fenofibrate—coronary artery disease	0.00929	0.0186	CbGbCtD
Methadone—CYP2C8—Clopidogrel—coronary artery disease	0.00923	0.0185	CbGbCtD
Methadone—CYP2C19—Gemfibrozil—coronary artery disease	0.00893	0.0179	CbGbCtD
Methadone—CYP3A5—Eplerenone—coronary artery disease	0.00892	0.0179	CbGbCtD
Methadone—CYP1A2—Gemfibrozil—coronary artery disease	0.00824	0.0165	CbGbCtD
Methadone—CYP2C8—Pitavastatin—coronary artery disease	0.00807	0.0162	CbGbCtD
Methadone—CYP2C19—Clopidogrel—coronary artery disease	0.00774	0.0155	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00766	0.0154	CbGbCtD
Methadone—CYP3A7—Simvastatin—coronary artery disease	0.00766	0.0154	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0075	0.0151	CbGbCtD
Methadone—CYP3A7—Lovastatin—coronary artery disease	0.0075	0.0151	CbGbCtD
Methadone—CYP2C9—Gemfibrozil—coronary artery disease	0.00742	0.0149	CbGbCtD
Methadone—CYP2B6—Simvastatin—coronary artery disease	0.0073	0.0147	CbGbCtD
Methadone—CYP1A2—Clopidogrel—coronary artery disease	0.00714	0.0143	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00683	0.0137	CbGbCtD
Methadone—CYP3A7—Atorvastatin—coronary artery disease	0.00683	0.0137	CbGbCtD
Methadone—CYP2C19—Telmisartan—coronary artery disease	0.00677	0.0136	CbGbCtD
Methadone—CYP2B6—Atorvastatin—coronary artery disease	0.00651	0.0131	CbGbCtD
Methadone—CYP2C9—Clopidogrel—coronary artery disease	0.00644	0.0129	CbGbCtD
Methadone—ABCB1—Clopidogrel—coronary artery disease	0.00625	0.0125	CbGbCtD
Methadone—ABCB1—Perindopril—coronary artery disease	0.00625	0.0125	CbGbCtD
Methadone—CYP3A5—Rosuvastatin—coronary artery disease	0.00618	0.0124	CbGbCtD
Methadone—CYP3A4—Ticagrelor—coronary artery disease	0.00606	0.0122	CbGbCtD
Methadone—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0058	0.0116	CbGbCtD
Methadone—CYP3A5—Simvastatin—coronary artery disease	0.00575	0.0115	CbGbCtD
Methadone—CYP3A5—Pravastatin—coronary artery disease	0.00563	0.0113	CbGbCtD
Methadone—CYP3A5—Lovastatin—coronary artery disease	0.00563	0.0113	CbGbCtD
Methadone—CYP2C9—Pitavastatin—coronary artery disease	0.00563	0.0113	CbGbCtD
Methadone—CYP2C8—Simvastatin—coronary artery disease	0.00553	0.0111	CbGbCtD
Methadone—CYP2C9—Valsartan—coronary artery disease	0.00547	0.011	CbGbCtD
Methadone—ABCB1—Pitavastatin—coronary artery disease	0.00546	0.011	CbGbCtD
Methadone—ABCB1—Telmisartan—coronary artery disease	0.00546	0.011	CbGbCtD
Methadone—CYP2C19—Timolol—coronary artery disease	0.00545	0.011	CbGbCtD
Methadone—CYP2C8—Pravastatin—coronary artery disease	0.00541	0.0109	CbGbCtD
Methadone—CYP2C8—Lovastatin—coronary artery disease	0.00541	0.0109	CbGbCtD
Methadone—CYP3A4—Fenofibrate—coronary artery disease	0.0054	0.0108	CbGbCtD
Methadone—ABCB1—Enalapril—coronary artery disease	0.00518	0.0104	CbGbCtD
Methadone—ABCB1—Lisinopril—coronary artery disease	0.00518	0.0104	CbGbCtD
Methadone—CYP3A5—Atorvastatin—coronary artery disease	0.00512	0.0103	CbGbCtD
Methadone—CYP2C19—Rosuvastatin—coronary artery disease	0.00499	0.01	CbGbCtD
Methadone—CYP2C8—Atorvastatin—coronary artery disease	0.00493	0.00989	CbGbCtD
Methadone—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00486	0.00976	CbGbCtD
Methadone—CYP3A5—Losartan—coronary artery disease	0.00469	0.00941	CbGbCtD
Methadone—CYP2C19—Simvastatin—coronary artery disease	0.00464	0.00931	CbGbCtD
Methadone—CYP2C19—Lovastatin—coronary artery disease	0.00454	0.00911	CbGbCtD
Methadone—CYP2C8—Losartan—coronary artery disease	0.00451	0.00905	CbGbCtD
Methadone—CYP2D6—Niacin—coronary artery disease	0.00446	0.00896	CbGbCtD
Methadone—ABCB1—Timolol—coronary artery disease	0.0044	0.00884	CbGbCtD
Methadone—CYP3A4—Gemfibrozil—coronary artery disease	0.00432	0.00867	CbGbCtD
Methadone—CYP2C9—Rosuvastatin—coronary artery disease	0.00415	0.00833	CbGbCtD
Methadone—CYP2D6—Timolol—coronary artery disease	0.00415	0.00833	CbGbCtD
Methadone—CYP2C19—Atorvastatin—coronary artery disease	0.00413	0.0083	CbGbCtD
Methadone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00404	0.00812	CbGbCtD
Methadone—ABCB1—Ezetimibe—coronary artery disease	0.00403	0.00808	CbGbCtD
Methadone—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00392	0.00788	CbGbCtD
Methadone—ABCB1—Captopril—coronary artery disease	0.00387	0.00778	CbGbCtD
Methadone—CYP2C9—Simvastatin—coronary artery disease	0.00386	0.00774	CbGbCtD
Methadone—CYP2C19—Losartan—coronary artery disease	0.00378	0.00759	CbGbCtD
Methadone—CYP2C9—Lovastatin—coronary artery disease	0.00377	0.00758	CbGbCtD
Methadone—CYP2C9—Pravastatin—coronary artery disease	0.00377	0.00758	CbGbCtD
Methadone—CYP3A4—Clopidogrel—coronary artery disease	0.00374	0.00751	CbGbCtD
Methadone—ABCB1—Simvastatin—coronary artery disease	0.00374	0.00751	CbGbCtD
Methadone—ABCB1—Pravastatin—coronary artery disease	0.00366	0.00735	CbGbCtD
Methadone—ABCB1—Lovastatin—coronary artery disease	0.00366	0.00735	CbGbCtD
Methadone—CYP2D6—Captopril—coronary artery disease	0.00365	0.00733	CbGbCtD
Methadone—CYP2D6—Simvastatin—coronary artery disease	0.00353	0.00708	CbGbCtD
Methadone—CYP1A2—Losartan—coronary artery disease	0.00349	0.007	CbGbCtD
Methadone—CYP3A4—Eplerenone—coronary artery disease	0.00348	0.00699	CbGbCtD
Methadone—CYP2D6—Lovastatin—coronary artery disease	0.00345	0.00693	CbGbCtD
Methadone—CYP2D6—Pravastatin—coronary artery disease	0.00345	0.00693	CbGbCtD
Methadone—CYP2C9—Atorvastatin—coronary artery disease	0.00344	0.0069	CbGbCtD
Methadone—ABCB1—Atorvastatin—coronary artery disease	0.00334	0.0067	CbGbCtD
Methadone—CYP2C9—Losartan—coronary artery disease	0.00314	0.00631	CbGbCtD
Methadone—CYP2D6—Atorvastatin—coronary artery disease	0.00314	0.00631	CbGbCtD
Methadone—CYP3A4—Enalapril—coronary artery disease	0.0031	0.00623	CbGbCtD
Methadone—ABCB1—Losartan—coronary artery disease	0.00305	0.00613	CbGbCtD
Methadone—CYP3A4—Ezetimibe—coronary artery disease	0.00241	0.00484	CbGbCtD
Methadone—CYP3A4—Rosuvastatin—coronary artery disease	0.00241	0.00484	CbGbCtD
Methadone—CYP3A4—Simvastatin—coronary artery disease	0.00224	0.0045	CbGbCtD
Methadone—CYP3A4—Pravastatin—coronary artery disease	0.00219	0.00441	CbGbCtD
Methadone—CYP3A4—Lovastatin—coronary artery disease	0.00219	0.00441	CbGbCtD
Methadone—CYP3A4—Atorvastatin—coronary artery disease	0.002	0.00401	CbGbCtD
Methadone—CYP3A4—Losartan—coronary artery disease	0.00183	0.00367	CbGbCtD
Methadone—CYP2C9—cardial valve—coronary artery disease	0.000942	0.356	CbGeAlD
Methadone—HTR3A—vagus nerve—coronary artery disease	0.000733	0.277	CbGeAlD
Methadone—Diphenoxylate—OPRD1—coronary artery disease	0.000348	0.154	CrCbGaD
Methadone—Tamoxifen—SULT1A1—coronary artery disease	0.000298	0.132	CrCbGaD
Methadone—Loperamide—POMC—coronary artery disease	0.000256	0.114	CrCbGaD
Methadone—CHRNA10—blood—coronary artery disease	0.000171	0.0646	CbGeAlD
Methadone—Dextropropoxyphene—OPRD1—coronary artery disease	0.000151	0.0672	CrCbGaD
Methadone—Fentanyl—OPRD1—coronary artery disease	0.00015	0.0664	CrCbGaD
Methadone—Loperamide—OPRD1—coronary artery disease	0.000144	0.064	CrCbGaD
Methadone—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000129	0.0571	CrCbGaD
Methadone—Tamoxifen—ESR2—coronary artery disease	8.37e-05	0.0371	CrCbGaD
Methadone—HTR3A—blood—coronary artery disease	7.93e-05	0.0299	CbGeAlD
Methadone—Abdominal pain—Telmisartan—coronary artery disease	7.57e-05	0.000613	CcSEcCtD
Methadone—Anxiety—Ramipril—coronary artery disease	7.55e-05	0.000612	CcSEcCtD
Methadone—Vomiting—Lovastatin—coronary artery disease	7.54e-05	0.000611	CcSEcCtD
Methadone—Somnolence—Losartan—coronary artery disease	7.53e-05	0.00061	CcSEcCtD
Methadone—Dizziness—Eplerenone—coronary artery disease	7.53e-05	0.00061	CcSEcCtD
Methadone—Rash—Clopidogrel—coronary artery disease	7.53e-05	0.00061	CcSEcCtD
Methadone—Dermatitis—Clopidogrel—coronary artery disease	7.52e-05	0.000609	CcSEcCtD
Methadone—Asthenia—Valsartan—coronary artery disease	7.52e-05	0.000609	CcSEcCtD
Methadone—Pain—Furosemide—coronary artery disease	7.51e-05	0.000608	CcSEcCtD
Methadone—Constipation—Furosemide—coronary artery disease	7.51e-05	0.000608	CcSEcCtD
Methadone—Hypersensitivity—Niacin—coronary artery disease	7.51e-05	0.000608	CcSEcCtD
Methadone—Asthenia—Olmesartan—coronary artery disease	7.48e-05	0.000606	CcSEcCtD
Methadone—Headache—Clopidogrel—coronary artery disease	7.48e-05	0.000606	CcSEcCtD
Methadone—Rash—Lovastatin—coronary artery disease	7.48e-05	0.000606	CcSEcCtD
Methadone—Dermatitis—Lovastatin—coronary artery disease	7.47e-05	0.000605	CcSEcCtD
Methadone—Feeling abnormal—Perindopril—coronary artery disease	7.45e-05	0.000603	CcSEcCtD
Methadone—Headache—Lovastatin—coronary artery disease	7.43e-05	0.000602	CcSEcCtD
Methadone—Pruritus—Valsartan—coronary artery disease	7.41e-05	0.0006	CcSEcCtD
Methadone—Dry mouth—Ramipril—coronary artery disease	7.41e-05	0.0006	CcSEcCtD
Methadone—Vomiting—Ezetimibe—coronary artery disease	7.4e-05	0.000599	CcSEcCtD
Methadone—Hypersensitivity—Pravastatin—coronary artery disease	7.39e-05	0.000599	CcSEcCtD
Methadone—Gastrointestinal pain—Perindopril—coronary artery disease	7.39e-05	0.000598	CcSEcCtD
Methadone—Anxiety—Timolol—coronary artery disease	7.39e-05	0.000598	CcSEcCtD
Methadone—Pruritus—Olmesartan—coronary artery disease	7.38e-05	0.000598	CcSEcCtD
Methadone—Decreased appetite—Losartan—coronary artery disease	7.37e-05	0.000597	CcSEcCtD
Methadone—Oxaprozin—PTGS2—coronary artery disease	7.36e-05	0.0326	CrCbGaD
Methadone—Abdominal pain—Captopril—coronary artery disease	7.36e-05	0.000596	CcSEcCtD
Methadone—Body temperature increased—Captopril—coronary artery disease	7.36e-05	0.000596	CcSEcCtD
Methadone—Dizziness—Simvastatin—coronary artery disease	7.34e-05	0.000594	CcSEcCtD
Methadone—Rash—Ezetimibe—coronary artery disease	7.34e-05	0.000594	CcSEcCtD
Methadone—Dermatitis—Ezetimibe—coronary artery disease	7.33e-05	0.000594	CcSEcCtD
Methadone—Confusional state—Ramipril—coronary artery disease	7.33e-05	0.000593	CcSEcCtD
Methadone—Asthenia—Niacin—coronary artery disease	7.31e-05	0.000592	CcSEcCtD
Methadone—Headache—Ezetimibe—coronary artery disease	7.29e-05	0.00059	CcSEcCtD
Methadone—OPRM1—blood—coronary artery disease	7.27e-05	0.0274	CbGeAlD
Methadone—Oedema—Ramipril—coronary artery disease	7.27e-05	0.000589	CcSEcCtD
Methadone—Anaphylactic shock—Ramipril—coronary artery disease	7.27e-05	0.000589	CcSEcCtD
Methadone—Vertigo—Lisinopril—coronary artery disease	7.26e-05	0.000588	CcSEcCtD
Methadone—Dry mouth—Timolol—coronary artery disease	7.25e-05	0.000587	CcSEcCtD
Methadone—Pain—Losartan—coronary artery disease	7.25e-05	0.000587	CcSEcCtD
Methadone—Constipation—Losartan—coronary artery disease	7.25e-05	0.000587	CcSEcCtD
Methadone—Syncope—Lisinopril—coronary artery disease	7.24e-05	0.000587	CcSEcCtD
Methadone—Vomiting—Eplerenone—coronary artery disease	7.24e-05	0.000586	CcSEcCtD
Methadone—Feeling abnormal—Furosemide—coronary artery disease	7.24e-05	0.000586	CcSEcCtD
Methadone—Nausea—Fenofibrate—coronary artery disease	7.22e-05	0.000585	CcSEcCtD
Methadone—Pruritus—Niacin—coronary artery disease	7.21e-05	0.000584	CcSEcCtD
Methadone—Asthenia—Pravastatin—coronary artery disease	7.2e-05	0.000583	CcSEcCtD
Methadone—Gastrointestinal pain—Furosemide—coronary artery disease	7.18e-05	0.000582	CcSEcCtD
Methadone—Rash—Eplerenone—coronary artery disease	7.18e-05	0.000582	CcSEcCtD
Methadone—Urticaria—Perindopril—coronary artery disease	7.18e-05	0.000581	CcSEcCtD
Methadone—Hypersensitivity—Trandolapril—coronary artery disease	7.18e-05	0.000581	CcSEcCtD
Methadone—Dermatitis—Eplerenone—coronary artery disease	7.17e-05	0.000581	CcSEcCtD
Methadone—Diarrhoea—Valsartan—coronary artery disease	7.17e-05	0.000581	CcSEcCtD
Methadone—Confusional state—Timolol—coronary artery disease	7.16e-05	0.00058	CcSEcCtD
Methadone—Shock—Ramipril—coronary artery disease	7.15e-05	0.000579	CcSEcCtD
Methadone—Hypersensitivity—Enalapril—coronary artery disease	7.15e-05	0.000579	CcSEcCtD
Methadone—Body temperature increased—Perindopril—coronary artery disease	7.14e-05	0.000579	CcSEcCtD
Methadone—Abdominal pain—Perindopril—coronary artery disease	7.14e-05	0.000579	CcSEcCtD
Methadone—Palpitations—Lisinopril—coronary artery disease	7.14e-05	0.000578	CcSEcCtD
Methadone—Diarrhoea—Olmesartan—coronary artery disease	7.14e-05	0.000578	CcSEcCtD
Methadone—Headache—Eplerenone—coronary artery disease	7.13e-05	0.000578	CcSEcCtD
Methadone—Thrombocytopenia—Ramipril—coronary artery disease	7.12e-05	0.000576	CcSEcCtD
Methadone—Oedema—Timolol—coronary artery disease	7.1e-05	0.000575	CcSEcCtD
Methadone—Anaphylactic shock—Timolol—coronary artery disease	7.1e-05	0.000575	CcSEcCtD
Methadone—Pruritus—Pravastatin—coronary artery disease	7.1e-05	0.000575	CcSEcCtD
Methadone—Loss of consciousness—Lisinopril—coronary artery disease	7.1e-05	0.000575	CcSEcCtD
Methadone—Nausea—Clopidogrel—coronary artery disease	7.09e-05	0.000575	CcSEcCtD
Methadone—Tachycardia—Ramipril—coronary artery disease	7.09e-05	0.000574	CcSEcCtD
Methadone—Vomiting—Simvastatin—coronary artery disease	7.06e-05	0.000571	CcSEcCtD
Methadone—Hypersensitivity—Telmisartan—coronary artery disease	7.05e-05	0.000571	CcSEcCtD
Methadone—Nausea—Lovastatin—coronary artery disease	7.05e-05	0.000571	CcSEcCtD
Methadone—Hyperhidrosis—Ramipril—coronary artery disease	7.03e-05	0.000569	CcSEcCtD
Methadone—Clotrimazole—CYP2C19—coronary artery disease	7e-05	0.031	CrCbGaD
Methadone—Rash—Simvastatin—coronary artery disease	7e-05	0.000567	CcSEcCtD
Methadone—Dermatitis—Simvastatin—coronary artery disease	6.99e-05	0.000566	CcSEcCtD
Methadone—Asthenia—Trandolapril—coronary artery disease	6.99e-05	0.000566	CcSEcCtD
Methadone—Shock—Timolol—coronary artery disease	6.99e-05	0.000566	CcSEcCtD
Methadone—Feeling abnormal—Losartan—coronary artery disease	6.98e-05	0.000566	CcSEcCtD
Methadone—Urticaria—Furosemide—coronary artery disease	6.98e-05	0.000565	CcSEcCtD
Methadone—Diarrhoea—Niacin—coronary artery disease	6.97e-05	0.000565	CcSEcCtD
Methadone—Asthenia—Enalapril—coronary artery disease	6.96e-05	0.000564	CcSEcCtD
Methadone—Headache—Simvastatin—coronary artery disease	6.95e-05	0.000563	CcSEcCtD
Methadone—Body temperature increased—Furosemide—coronary artery disease	6.94e-05	0.000562	CcSEcCtD
Methadone—Abdominal pain—Furosemide—coronary artery disease	6.94e-05	0.000562	CcSEcCtD
Methadone—Gastrointestinal pain—Losartan—coronary artery disease	6.93e-05	0.000561	CcSEcCtD
Methadone—Dizziness—Valsartan—coronary artery disease	6.93e-05	0.000561	CcSEcCtD
Methadone—Anorexia—Ramipril—coronary artery disease	6.93e-05	0.000561	CcSEcCtD
Methadone—Nausea—Ezetimibe—coronary artery disease	6.91e-05	0.00056	CcSEcCtD
Methadone—Dizziness—Olmesartan—coronary artery disease	6.9e-05	0.000559	CcSEcCtD
Methadone—Pruritus—Trandolapril—coronary artery disease	6.89e-05	0.000558	CcSEcCtD
Methadone—Hyperhidrosis—Timolol—coronary artery disease	6.87e-05	0.000556	CcSEcCtD
Methadone—Asthenia—Telmisartan—coronary artery disease	6.87e-05	0.000556	CcSEcCtD
Methadone—Pruritus—Enalapril—coronary artery disease	6.86e-05	0.000556	CcSEcCtD
Methadone—Diarrhoea—Pravastatin—coronary artery disease	6.86e-05	0.000556	CcSEcCtD
Methadone—Anxiety—Lisinopril—coronary artery disease	6.85e-05	0.000555	CcSEcCtD
Methadone—Hypotension—Ramipril—coronary artery disease	6.79e-05	0.00055	CcSEcCtD
Methadone—Anorexia—Timolol—coronary artery disease	6.77e-05	0.000548	CcSEcCtD
Methadone—Pruritus—Telmisartan—coronary artery disease	6.77e-05	0.000548	CcSEcCtD
Methadone—Nausea—Eplerenone—coronary artery disease	6.76e-05	0.000548	CcSEcCtD
Methadone—Dizziness—Niacin—coronary artery disease	6.74e-05	0.000546	CcSEcCtD
Methadone—Urticaria—Losartan—coronary artery disease	6.73e-05	0.000545	CcSEcCtD
Methadone—Dry mouth—Lisinopril—coronary artery disease	6.72e-05	0.000545	CcSEcCtD
Methadone—Abdominal pain—Losartan—coronary artery disease	6.7e-05	0.000543	CcSEcCtD
Methadone—Body temperature increased—Losartan—coronary artery disease	6.7e-05	0.000543	CcSEcCtD
Methadone—Asthenia—Captopril—coronary artery disease	6.68e-05	0.000541	CcSEcCtD
Methadone—Diarrhoea—Trandolapril—coronary artery disease	6.67e-05	0.00054	CcSEcCtD
Methadone—Vomiting—Valsartan—coronary artery disease	6.66e-05	0.00054	CcSEcCtD
Methadone—Confusional state—Lisinopril—coronary artery disease	6.65e-05	0.000538	CcSEcCtD
Methadone—Diarrhoea—Enalapril—coronary artery disease	6.64e-05	0.000538	CcSEcCtD
Methadone—Hypotension—Timolol—coronary artery disease	6.64e-05	0.000538	CcSEcCtD
Methadone—Dizziness—Pravastatin—coronary artery disease	6.63e-05	0.000537	CcSEcCtD
Methadone—Vomiting—Olmesartan—coronary artery disease	6.63e-05	0.000537	CcSEcCtD
Methadone—Rash—Valsartan—coronary artery disease	6.61e-05	0.000535	CcSEcCtD
Methadone—Dermatitis—Valsartan—coronary artery disease	6.6e-05	0.000535	CcSEcCtD
Methadone—Nausea—Simvastatin—coronary artery disease	6.59e-05	0.000534	CcSEcCtD
Methadone—Oedema—Lisinopril—coronary artery disease	6.59e-05	0.000534	CcSEcCtD
Methadone—Anaphylactic shock—Lisinopril—coronary artery disease	6.59e-05	0.000534	CcSEcCtD
Methadone—Pruritus—Captopril—coronary artery disease	6.58e-05	0.000533	CcSEcCtD
Methadone—Rash—Olmesartan—coronary artery disease	6.58e-05	0.000533	CcSEcCtD
Methadone—Insomnia—Ramipril—coronary artery disease	6.57e-05	0.000532	CcSEcCtD
Methadone—Dermatitis—Olmesartan—coronary artery disease	6.57e-05	0.000532	CcSEcCtD
Methadone—Headache—Valsartan—coronary artery disease	6.56e-05	0.000532	CcSEcCtD
Methadone—Diarrhoea—Telmisartan—coronary artery disease	6.55e-05	0.00053	CcSEcCtD
Methadone—Headache—Olmesartan—coronary artery disease	6.53e-05	0.000529	CcSEcCtD
Methadone—Shock—Lisinopril—coronary artery disease	6.48e-05	0.000525	CcSEcCtD
Methadone—Asthenia—Perindopril—coronary artery disease	6.48e-05	0.000525	CcSEcCtD
Methadone—Vomiting—Niacin—coronary artery disease	6.48e-05	0.000525	CcSEcCtD
Methadone—Hypersensitivity—Furosemide—coronary artery disease	6.47e-05	0.000524	CcSEcCtD
Methadone—Somnolence—Ramipril—coronary artery disease	6.46e-05	0.000523	CcSEcCtD
Methadone—Thrombocytopenia—Lisinopril—coronary artery disease	6.45e-05	0.000523	CcSEcCtD
Methadone—Dizziness—Trandolapril—coronary artery disease	6.44e-05	0.000522	CcSEcCtD
Methadone—Tachycardia—Lisinopril—coronary artery disease	6.43e-05	0.000521	CcSEcCtD
Methadone—Insomnia—Timolol—coronary artery disease	6.43e-05	0.00052	CcSEcCtD
Methadone—Rash—Niacin—coronary artery disease	6.42e-05	0.00052	CcSEcCtD
Methadone—Dermatitis—Niacin—coronary artery disease	6.42e-05	0.00052	CcSEcCtD
Methadone—Dizziness—Enalapril—coronary artery disease	6.42e-05	0.00052	CcSEcCtD
Methadone—Pruritus—Perindopril—coronary artery disease	6.39e-05	0.000518	CcSEcCtD
Methadone—Headache—Niacin—coronary artery disease	6.38e-05	0.000517	CcSEcCtD
Methadone—Vomiting—Pravastatin—coronary artery disease	6.38e-05	0.000517	CcSEcCtD
Methadone—Hyperhidrosis—Lisinopril—coronary artery disease	6.37e-05	0.000516	CcSEcCtD
Methadone—Diarrhoea—Captopril—coronary artery disease	6.37e-05	0.000516	CcSEcCtD
Methadone—Dizziness—Telmisartan—coronary artery disease	6.33e-05	0.000513	CcSEcCtD
Methadone—Rash—Pravastatin—coronary artery disease	6.33e-05	0.000512	CcSEcCtD
Methadone—Dermatitis—Pravastatin—coronary artery disease	6.32e-05	0.000512	CcSEcCtD
Methadone—Decreased appetite—Ramipril—coronary artery disease	6.32e-05	0.000512	CcSEcCtD
Methadone—Somnolence—Timolol—coronary artery disease	6.32e-05	0.000512	CcSEcCtD
Methadone—Asthenia—Furosemide—coronary artery disease	6.3e-05	0.00051	CcSEcCtD
Methadone—Headache—Pravastatin—coronary artery disease	6.28e-05	0.000509	CcSEcCtD
Methadone—Anorexia—Lisinopril—coronary artery disease	6.28e-05	0.000509	CcSEcCtD
Methadone—Hypersensitivity—Losartan—coronary artery disease	6.24e-05	0.000506	CcSEcCtD
Methadone—Nausea—Valsartan—coronary artery disease	6.22e-05	0.000504	CcSEcCtD
Methadone—Pruritus—Furosemide—coronary artery disease	6.21e-05	0.000503	CcSEcCtD
Methadone—Constipation—Ramipril—coronary artery disease	6.21e-05	0.000503	CcSEcCtD
Methadone—Nausea—Olmesartan—coronary artery disease	6.19e-05	0.000502	CcSEcCtD
Methadone—Vomiting—Trandolapril—coronary artery disease	6.19e-05	0.000502	CcSEcCtD
Methadone—Diarrhoea—Perindopril—coronary artery disease	6.18e-05	0.000501	CcSEcCtD
Methadone—Decreased appetite—Timolol—coronary artery disease	6.18e-05	0.0005	CcSEcCtD
Methadone—Vomiting—Enalapril—coronary artery disease	6.17e-05	0.0005	CcSEcCtD
Methadone—Hypotension—Lisinopril—coronary artery disease	6.16e-05	0.000499	CcSEcCtD
Methadone—Dizziness—Captopril—coronary artery disease	6.15e-05	0.000498	CcSEcCtD
Methadone—Rash—Trandolapril—coronary artery disease	6.14e-05	0.000498	CcSEcCtD
Methadone—Dermatitis—Trandolapril—coronary artery disease	6.14e-05	0.000497	CcSEcCtD
Methadone—Modafinil—CYP2C19—coronary artery disease	6.12e-05	0.0271	CrCbGaD
Methadone—Rash—Enalapril—coronary artery disease	6.12e-05	0.000496	CcSEcCtD
Methadone—Dermatitis—Enalapril—coronary artery disease	6.11e-05	0.000495	CcSEcCtD
Methadone—CYP19A1—blood—coronary artery disease	6.11e-05	0.0231	CbGeAlD
Methadone—Headache—Trandolapril—coronary artery disease	6.1e-05	0.000494	CcSEcCtD
Methadone—Vomiting—Telmisartan—coronary artery disease	6.09e-05	0.000493	CcSEcCtD
Methadone—Asthenia—Losartan—coronary artery disease	6.08e-05	0.000493	CcSEcCtD
Methadone—Headache—Enalapril—coronary artery disease	6.08e-05	0.000492	CcSEcCtD
Methadone—Pain—Timolol—coronary artery disease	6.08e-05	0.000492	CcSEcCtD
Methadone—Nausea—Niacin—coronary artery disease	6.05e-05	0.00049	CcSEcCtD
Methadone—Rash—Telmisartan—coronary artery disease	6.03e-05	0.000489	CcSEcCtD
Methadone—Dermatitis—Telmisartan—coronary artery disease	6.03e-05	0.000488	CcSEcCtD
Methadone—Diarrhoea—Furosemide—coronary artery disease	6.01e-05	0.000487	CcSEcCtD
Methadone—Pruritus—Losartan—coronary artery disease	6e-05	0.000486	CcSEcCtD
Methadone—Headache—Telmisartan—coronary artery disease	6e-05	0.000486	CcSEcCtD
Methadone—Feeling abnormal—Ramipril—coronary artery disease	5.99e-05	0.000485	CcSEcCtD
Methadone—Dizziness—Perindopril—coronary artery disease	5.98e-05	0.000484	CcSEcCtD
Methadone—Insomnia—Lisinopril—coronary artery disease	5.96e-05	0.000483	CcSEcCtD
Methadone—Nausea—Pravastatin—coronary artery disease	5.96e-05	0.000483	CcSEcCtD
Methadone—Gastrointestinal pain—Ramipril—coronary artery disease	5.94e-05	0.000481	CcSEcCtD
Methadone—Vomiting—Captopril—coronary artery disease	5.92e-05	0.000479	CcSEcCtD
Methadone—Phenoxybenzamine—ADRB2—coronary artery disease	5.89e-05	0.0261	CrCbGaD
Methadone—Rash—Captopril—coronary artery disease	5.87e-05	0.000475	CcSEcCtD
Methadone—Dermatitis—Captopril—coronary artery disease	5.86e-05	0.000475	CcSEcCtD
Methadone—Somnolence—Lisinopril—coronary artery disease	5.86e-05	0.000475	CcSEcCtD
Methadone—Feeling abnormal—Timolol—coronary artery disease	5.85e-05	0.000474	CcSEcCtD
Methadone—Headache—Captopril—coronary artery disease	5.83e-05	0.000472	CcSEcCtD
Methadone—Gastrointestinal pain—Timolol—coronary artery disease	5.81e-05	0.000471	CcSEcCtD
Methadone—Dizziness—Furosemide—coronary artery disease	5.81e-05	0.00047	CcSEcCtD
Methadone—Diarrhoea—Losartan—coronary artery disease	5.8e-05	0.00047	CcSEcCtD
Methadone—Nausea—Trandolapril—coronary artery disease	5.79e-05	0.000469	CcSEcCtD
Methadone—Urticaria—Ramipril—coronary artery disease	5.77e-05	0.000468	CcSEcCtD
Methadone—Nausea—Enalapril—coronary artery disease	5.76e-05	0.000467	CcSEcCtD
Methadone—Vomiting—Perindopril—coronary artery disease	5.75e-05	0.000465	CcSEcCtD
Methadone—Abdominal pain—Ramipril—coronary artery disease	5.74e-05	0.000465	CcSEcCtD
Methadone—Body temperature increased—Ramipril—coronary artery disease	5.74e-05	0.000465	CcSEcCtD
Methadone—Decreased appetite—Lisinopril—coronary artery disease	5.73e-05	0.000464	CcSEcCtD
Methadone—Rash—Perindopril—coronary artery disease	5.7e-05	0.000461	CcSEcCtD
Methadone—Dermatitis—Perindopril—coronary artery disease	5.69e-05	0.000461	CcSEcCtD
Methadone—Nausea—Telmisartan—coronary artery disease	5.68e-05	0.00046	CcSEcCtD
Methadone—Headache—Perindopril—coronary artery disease	5.66e-05	0.000458	CcSEcCtD
Methadone—Urticaria—Timolol—coronary artery disease	5.64e-05	0.000457	CcSEcCtD
Methadone—Pain—Lisinopril—coronary artery disease	5.64e-05	0.000456	CcSEcCtD
Methadone—Constipation—Lisinopril—coronary artery disease	5.64e-05	0.000456	CcSEcCtD
Methadone—Body temperature increased—Timolol—coronary artery disease	5.62e-05	0.000455	CcSEcCtD
Methadone—Abdominal pain—Timolol—coronary artery disease	5.62e-05	0.000455	CcSEcCtD
Methadone—Dizziness—Losartan—coronary artery disease	5.6e-05	0.000454	CcSEcCtD
Methadone—Vomiting—Furosemide—coronary artery disease	5.58e-05	0.000452	CcSEcCtD
Methadone—Rash—Furosemide—coronary artery disease	5.54e-05	0.000449	CcSEcCtD
Methadone—Dermatitis—Furosemide—coronary artery disease	5.53e-05	0.000448	CcSEcCtD
Methadone—Nausea—Captopril—coronary artery disease	5.53e-05	0.000448	CcSEcCtD
Methadone—Headache—Furosemide—coronary artery disease	5.5e-05	0.000446	CcSEcCtD
Methadone—Feeling abnormal—Lisinopril—coronary artery disease	5.43e-05	0.00044	CcSEcCtD
Methadone—Gastrointestinal pain—Lisinopril—coronary artery disease	5.39e-05	0.000437	CcSEcCtD
Methadone—Vomiting—Losartan—coronary artery disease	5.39e-05	0.000436	CcSEcCtD
Methadone—Nausea—Perindopril—coronary artery disease	5.37e-05	0.000435	CcSEcCtD
Methadone—Hypersensitivity—Ramipril—coronary artery disease	5.35e-05	0.000434	CcSEcCtD
Methadone—Rash—Losartan—coronary artery disease	5.34e-05	0.000433	CcSEcCtD
Methadone—Dermatitis—Losartan—coronary artery disease	5.34e-05	0.000432	CcSEcCtD
Methadone—Headache—Losartan—coronary artery disease	5.31e-05	0.00043	CcSEcCtD
Methadone—Atomoxetine—CYP2C19—coronary artery disease	5.26e-05	0.0233	CrCbGaD
Methadone—CYP2B6—heart—coronary artery disease	5.26e-05	0.0198	CbGeAlD
Methadone—Urticaria—Lisinopril—coronary artery disease	5.24e-05	0.000424	CcSEcCtD
Methadone—Hypersensitivity—Timolol—coronary artery disease	5.23e-05	0.000424	CcSEcCtD
Methadone—Nausea—Furosemide—coronary artery disease	5.22e-05	0.000423	CcSEcCtD
Methadone—Asthenia—Ramipril—coronary artery disease	5.21e-05	0.000422	CcSEcCtD
Methadone—Abdominal pain—Lisinopril—coronary artery disease	5.21e-05	0.000422	CcSEcCtD
Methadone—Body temperature increased—Lisinopril—coronary artery disease	5.21e-05	0.000422	CcSEcCtD
Methadone—CYP2C9—heart—coronary artery disease	5.21e-05	0.0196	CbGeAlD
Methadone—Tamoxifen—ESR1—coronary artery disease	5.16e-05	0.0229	CrCbGaD
Methadone—Pruritus—Ramipril—coronary artery disease	5.14e-05	0.000416	CcSEcCtD
Methadone—Asthenia—Timolol—coronary artery disease	5.1e-05	0.000413	CcSEcCtD
Methadone—Nausea—Losartan—coronary artery disease	5.03e-05	0.000408	CcSEcCtD
Methadone—Pruritus—Timolol—coronary artery disease	5.03e-05	0.000407	CcSEcCtD
Methadone—CYP2C19—blood—coronary artery disease	5.01e-05	0.0189	CbGeAlD
Methadone—Diarrhoea—Ramipril—coronary artery disease	4.97e-05	0.000403	CcSEcCtD
Methadone—CYP2B6—cardiovascular system—coronary artery disease	4.96e-05	0.0187	CbGeAlD
Methadone—CYP2C9—cardiovascular system—coronary artery disease	4.91e-05	0.0185	CbGeAlD
Methadone—Phenylbutazone—PTGS2—coronary artery disease	4.87e-05	0.0216	CrCbGaD
Methadone—Diarrhoea—Timolol—coronary artery disease	4.86e-05	0.000394	CcSEcCtD
Methadone—Hypersensitivity—Lisinopril—coronary artery disease	4.86e-05	0.000393	CcSEcCtD
Methadone—Dizziness—Ramipril—coronary artery disease	4.81e-05	0.000389	CcSEcCtD
Methadone—Asthenia—Lisinopril—coronary artery disease	4.73e-05	0.000383	CcSEcCtD
Methadone—Dizziness—Timolol—coronary artery disease	4.7e-05	0.000381	CcSEcCtD
Methadone—Pruritus—Lisinopril—coronary artery disease	4.66e-05	0.000378	CcSEcCtD
Methadone—Vomiting—Ramipril—coronary artery disease	4.62e-05	0.000374	CcSEcCtD
Methadone—Rash—Ramipril—coronary artery disease	4.58e-05	0.000371	CcSEcCtD
Methadone—Dermatitis—Ramipril—coronary artery disease	4.58e-05	0.000371	CcSEcCtD
Methadone—Headache—Ramipril—coronary artery disease	4.55e-05	0.000369	CcSEcCtD
Methadone—Vomiting—Timolol—coronary artery disease	4.52e-05	0.000366	CcSEcCtD
Methadone—Diarrhoea—Lisinopril—coronary artery disease	4.51e-05	0.000365	CcSEcCtD
Methadone—Rash—Timolol—coronary artery disease	4.48e-05	0.000363	CcSEcCtD
Methadone—Dermatitis—Timolol—coronary artery disease	4.48e-05	0.000362	CcSEcCtD
Methadone—Headache—Timolol—coronary artery disease	4.45e-05	0.00036	CcSEcCtD
Methadone—CYP2C8—blood—coronary artery disease	4.37e-05	0.0165	CbGeAlD
Methadone—Dizziness—Lisinopril—coronary artery disease	4.36e-05	0.000353	CcSEcCtD
Methadone—Trimipramine—CYP2C19—coronary artery disease	4.33e-05	0.0192	CrCbGaD
Methadone—Nausea—Ramipril—coronary artery disease	4.32e-05	0.00035	CcSEcCtD
Methadone—Atomoxetine—HTR2A—coronary artery disease	4.27e-05	0.0189	CrCbGaD
Methadone—Diphenhydramine—CYP2C19—coronary artery disease	4.25e-05	0.0189	CrCbGaD
Methadone—Nausea—Timolol—coronary artery disease	4.22e-05	0.000342	CcSEcCtD
Methadone—Vomiting—Lisinopril—coronary artery disease	4.19e-05	0.000339	CcSEcCtD
Methadone—Rash—Lisinopril—coronary artery disease	4.16e-05	0.000337	CcSEcCtD
Methadone—Dermatitis—Lisinopril—coronary artery disease	4.15e-05	0.000336	CcSEcCtD
Methadone—Tamoxifen—CYP2C19—coronary artery disease	4.14e-05	0.0184	CrCbGaD
Methadone—Headache—Lisinopril—coronary artery disease	4.13e-05	0.000334	CcSEcCtD
Methadone—CYP1A2—blood—coronary artery disease	4.09e-05	0.0154	CbGeAlD
Methadone—Propiomazine—HTR2A—coronary artery disease	4.01e-05	0.0178	CrCbGaD
Methadone—CYP3A5—blood—coronary artery disease	3.95e-05	0.0149	CbGeAlD
Methadone—CYP2B6—blood—coronary artery disease	3.92e-05	0.0148	CbGeAlD
Methadone—Nausea—Lisinopril—coronary artery disease	3.91e-05	0.000317	CcSEcCtD
Methadone—CYP2C9—blood—coronary artery disease	3.88e-05	0.0147	CbGeAlD
Methadone—Trimipramine—HTR2A—coronary artery disease	3.51e-05	0.0156	CrCbGaD
Methadone—Promethazine—HTR2A—coronary artery disease	3.38e-05	0.015	CrCbGaD
Methadone—CYP3A4—blood—coronary artery disease	2.96e-05	0.0112	CbGeAlD
Methadone—CYP2D6—blood—coronary artery disease	2.92e-05	0.011	CbGeAlD
Methadone—ABCB1—heart—coronary artery disease	2.81e-05	0.0106	CbGeAlD
Methadone—ABCB1—cardiovascular system—coronary artery disease	2.65e-05	0.01	CbGeAlD
Methadone—ABCB1—blood—coronary artery disease	2.1e-05	0.00791	CbGeAlD
Methadone—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	2.12e-06	2.82e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	2.12e-06	2.81e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.11e-06	2.81e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.11e-06	2.81e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.11e-06	2.81e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—coronary artery disease	2.11e-06	2.8e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GGT1—coronary artery disease	2.09e-06	2.79e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GOT1—coronary artery disease	2.09e-06	2.79e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AGT—coronary artery disease	2.09e-06	2.78e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GGT1—coronary artery disease	2.08e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GOT1—coronary artery disease	2.08e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CTGF—coronary artery disease	2.07e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—NOS3—coronary artery disease	2.07e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—LPL—coronary artery disease	2.07e-06	2.75e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.06e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GOT2—coronary artery disease	2.06e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOE—coronary artery disease	2.05e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.05e-06	2.72e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGF2—coronary artery disease	2.04e-06	2.72e-05	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	2.04e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AGT—coronary artery disease	2.04e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.03e-06	2.7e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—coronary artery disease	2.02e-06	2.69e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOA1—coronary artery disease	2.02e-06	2.69e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.02e-06	2.68e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPX1—coronary artery disease	2.02e-06	2.68e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOS3—coronary artery disease	2.02e-06	2.68e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—coronary artery disease	2.01e-06	2.68e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOE—coronary artery disease	2e-06	2.66e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—coronary artery disease	2e-06	2.66e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—VCAN—coronary artery disease	1.99e-06	2.65e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CAT—coronary artery disease	1.99e-06	2.65e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.98e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOA1—coronary artery disease	1.98e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.98e-06	2.63e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—coronary artery disease	1.97e-06	2.62e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—coronary artery disease	1.97e-06	2.62e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CD36—coronary artery disease	1.96e-06	2.61e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	1.96e-06	2.61e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JAK2—coronary artery disease	1.96e-06	2.61e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAT—coronary artery disease	1.94e-06	2.58e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.94e-06	2.58e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOB—coronary artery disease	1.93e-06	2.57e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.92e-06	2.55e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DCN—coronary artery disease	1.92e-06	2.55e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—coronary artery disease	1.91e-06	2.55e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.9e-06	2.52e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.89e-06	2.51e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOB—coronary artery disease	1.89e-06	2.51e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.88e-06	2.5e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.88e-06	2.5e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.87e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.86e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.86e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.86e-06	2.48e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	1.86e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.86e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.85e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.85e-06	2.46e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—LPL—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—coronary artery disease	1.83e-06	2.44e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.83e-06	2.44e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAT—coronary artery disease	1.83e-06	2.44e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HBA1—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LIPC—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAT—coronary artery disease	1.81e-06	2.41e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOC3—coronary artery disease	1.81e-06	2.4e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—LPL—coronary artery disease	1.8e-06	2.4e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPX1—coronary artery disease	1.8e-06	2.39e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	1.8e-06	2.39e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LDLR—coronary artery disease	1.8e-06	2.39e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	1.79e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—coronary artery disease	1.78e-06	2.37e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOB—coronary artery disease	1.78e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.77e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.77e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GGT1—coronary artery disease	1.77e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GOT1—coronary artery disease	1.77e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AGT—coronary artery disease	1.77e-06	2.35e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	1.76e-06	2.35e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOB—coronary artery disease	1.76e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—coronary artery disease	1.76e-06	2.34e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPX1—coronary artery disease	1.76e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—coronary artery disease	1.75e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCLC—coronary artery disease	1.75e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CETP—coronary artery disease	1.75e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CD36—coronary artery disease	1.75e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—coronary artery disease	1.74e-06	2.32e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SDC1—coronary artery disease	1.73e-06	2.31e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOE—coronary artery disease	1.73e-06	2.31e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.73e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.73e-06	2.3e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.73e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—coronary artery disease	1.72e-06	2.29e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	1.72e-06	2.29e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.71e-06	2.28e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOA1—coronary artery disease	1.71e-06	2.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—coronary artery disease	1.71e-06	2.28e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CD36—coronary artery disease	1.71e-06	2.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—coronary artery disease	1.7e-06	2.26e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—LPL—coronary artery disease	1.7e-06	2.26e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.69e-06	2.25e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—LPL—coronary artery disease	1.68e-06	2.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—coronary artery disease	1.67e-06	2.22e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.66e-06	2.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPX1—coronary artery disease	1.66e-06	2.2e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPX1—coronary artery disease	1.64e-06	2.18e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.64e-06	2.18e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.64e-06	2.18e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.64e-06	2.18e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—coronary artery disease	1.62e-06	2.16e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—coronary artery disease	1.62e-06	2.15e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CD36—coronary artery disease	1.61e-06	2.15e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—coronary artery disease	1.6e-06	2.13e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CTGF—coronary artery disease	1.6e-06	2.13e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CD36—coronary artery disease	1.6e-06	2.13e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.59e-06	2.12e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.59e-06	2.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.59e-06	2.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.59e-06	2.11e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.58e-06	2.1e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.58e-06	2.1e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AGT—coronary artery disease	1.58e-06	2.1e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	1.58e-06	2.1e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.57e-06	2.09e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	1.57e-06	2.09e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—coronary artery disease	1.57e-06	2.08e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAT—coronary artery disease	1.55e-06	2.06e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	1.55e-06	2.06e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOE—coronary artery disease	1.55e-06	2.06e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AGT—coronary artery disease	1.54e-06	2.05e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NOS3—coronary artery disease	1.53e-06	2.04e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.53e-06	2.04e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOA1—coronary artery disease	1.53e-06	2.03e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.53e-06	2.03e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.51e-06	2.02e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOE—coronary artery disease	1.51e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—coronary artery disease	1.51e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOB—coronary artery disease	1.51e-06	2e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NOS3—coronary artery disease	1.5e-06	1.99e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOA1—coronary artery disease	1.49e-06	1.99e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—coronary artery disease	1.49e-06	1.98e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.46e-06	1.95e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.46e-06	1.95e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.46e-06	1.94e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	1.45e-06	1.93e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AGT—coronary artery disease	1.45e-06	1.93e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AGT—coronary artery disease	1.44e-06	1.91e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—LPL—coronary artery disease	1.44e-06	1.91e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—coronary artery disease	1.43e-06	1.91e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOE—coronary artery disease	1.42e-06	1.89e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.41e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOE—coronary artery disease	1.41e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOA1—coronary artery disease	1.41e-06	1.87e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPX1—coronary artery disease	1.4e-06	1.87e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.4e-06	1.87e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOA1—coronary artery disease	1.39e-06	1.85e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GOT1—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GGT1—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CD36—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—coronary artery disease	1.36e-06	1.81e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—coronary artery disease	1.36e-06	1.8e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.35e-06	1.79e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—coronary artery disease	1.35e-06	1.79e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—coronary artery disease	1.34e-06	1.79e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	1.34e-06	1.79e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.33e-06	1.78e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	1.33e-06	1.77e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—coronary artery disease	1.33e-06	1.77e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—coronary artery disease	1.31e-06	1.75e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	1.31e-06	1.74e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NOS3—coronary artery disease	1.3e-06	1.73e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—coronary artery disease	1.3e-06	1.73e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.29e-06	1.72e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—coronary artery disease	1.25e-06	1.66e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—coronary artery disease	1.24e-06	1.65e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.23e-06	1.64e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AGT—coronary artery disease	1.23e-06	1.64e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—coronary artery disease	1.23e-06	1.63e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—coronary artery disease	1.22e-06	1.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.22e-06	1.62e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.21e-06	1.61e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—coronary artery disease	1.21e-06	1.61e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—coronary artery disease	1.21e-06	1.61e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOE—coronary artery disease	1.2e-06	1.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAT—coronary artery disease	1.2e-06	1.59e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOA1—coronary artery disease	1.19e-06	1.58e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—coronary artery disease	1.19e-06	1.58e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.19e-06	1.58e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—coronary artery disease	1.18e-06	1.57e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.17e-06	1.55e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOB—coronary artery disease	1.16e-06	1.55e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NOS3—coronary artery disease	1.16e-06	1.54e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.13e-06	1.51e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NOS3—coronary artery disease	1.13e-06	1.5e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.13e-06	1.5e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—coronary artery disease	1.11e-06	1.48e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LPL—coronary artery disease	1.11e-06	1.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—coronary artery disease	1.1e-06	1.47e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—coronary artery disease	1.1e-06	1.46e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—coronary artery disease	1.1e-06	1.46e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.08e-06	1.44e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NOS3—coronary artery disease	1.07e-06	1.42e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.06e-06	1.41e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NOS3—coronary artery disease	1.06e-06	1.41e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CD36—coronary artery disease	1.05e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—coronary artery disease	1.05e-06	1.4e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.04e-06	1.39e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—coronary artery disease	1.04e-06	1.38e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—coronary artery disease	1.03e-06	1.38e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—coronary artery disease	1e-06	1.34e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—coronary artery disease	9.99e-07	1.33e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—coronary artery disease	9.75e-07	1.3e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—coronary artery disease	9.66e-07	1.29e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—coronary artery disease	9.53e-07	1.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AGT—coronary artery disease	9.49e-07	1.26e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—coronary artery disease	9.44e-07	1.26e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOE—coronary artery disease	9.3e-07	1.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—coronary artery disease	9.26e-07	1.23e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOA1—coronary artery disease	9.19e-07	1.22e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NOS3—coronary artery disease	9.03e-07	1.2e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—coronary artery disease	8.63e-07	1.15e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	8.43e-07	1.12e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—coronary artery disease	8.26e-07	1.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—coronary artery disease	8.1e-07	1.08e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—coronary artery disease	7.99e-07	1.06e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—coronary artery disease	7.3e-07	9.72e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—coronary artery disease	7.28e-07	9.69e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—coronary artery disease	7.05e-07	9.38e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NOS3—coronary artery disease	6.97e-07	9.27e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—coronary artery disease	6.89e-07	9.17e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—coronary artery disease	6.52e-07	8.67e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—coronary artery disease	6.37e-07	8.48e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.36e-07	8.47e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6e-07	7.98e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—coronary artery disease	5.97e-07	7.94e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	5.94e-07	7.91e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—coronary artery disease	5.33e-07	7.09e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—coronary artery disease	5.2e-07	6.92e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.08e-07	6.76e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—coronary artery disease	4.9e-07	6.52e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—coronary artery disease	4.86e-07	6.46e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—coronary artery disease	4.15e-07	5.52e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.92e-07	5.22e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—coronary artery disease	3.2e-07	4.26e-06	CbGpPWpGaD
